These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3333794)

  • 1. Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse.
    Saxén H; Reima I; Mäkelä PH
    Microb Pathog; 1987 Jan; 2(1):15-28. PubMed ID: 3333794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella, complement and mouse macrophages.
    Mäkelä PH; Hovi M; Saxén H; Valtonen M; Valtonen V
    Immunol Lett; 1988 Nov; 19(3):217-22. PubMed ID: 2466776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.
    Liang-Takasaki CJ; Saxén H; Mäkelä PH; Leive L
    Infect Immun; 1983 Aug; 41(2):563-9. PubMed ID: 6347890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length.
    Grossman N; Leive L
    J Immunol; 1984 Jan; 132(1):376-85. PubMed ID: 6197450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.
    Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E
    Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody.
    Siggins MK; Cunningham AF; Marshall JL; Chamberlain JL; Henderson IR; MacLennan CA
    J Immunol; 2011 Feb; 186(4):2365-71. PubMed ID: 21217014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection.
    Warren J; Mastroeni P; Dougan G; Noursadeghi M; Cohen J; Walport MJ; Botto M
    Infect Immun; 2002 Feb; 70(2):551-7. PubMed ID: 11796582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin.
    Vladoianu IR; Chang HR; Pechère JC
    Microb Pathog; 1990 Feb; 8(2):83-90. PubMed ID: 2190062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural resistance of mice to Salmonella typhimurium: bactericidal activity and chemiluminescence response of murine peritoneal macrophages.
    Blumenstock E; Jann K
    J Gen Microbiol; 1981 Jul; 125(1):173-83. PubMed ID: 7038033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible mechanism for host-specific pathogenesis of Salmonella serovars.
    Ishibashi Y; Arai T
    Microb Pathog; 1996 Dec; 21(6):435-46. PubMed ID: 8971684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
    Grossman N; Joiner KA; Frank MM; Leive L
    J Immunol; 1986 Mar; 136(6):2208-15. PubMed ID: 3950413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sensitivity of complement to Salmonella typhimurium accounts for the difference in natural resistance to murine typhoid between A/J and C57BL/6 mice.
    Nakano A; Kita E; Kashiba S
    Microbiol Immunol; 1995; 39(2):95-103. PubMed ID: 7783691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella-typhimurium-specific difference in rate of intracellular killing by resident peritoneal macrophages from salmonella-resistant CBA and salmonella-susceptible C57BL/10 mice.
    van Dissel JT; Stikkelbroeck JJ; Michel BC; Leijh PC; van Furth R
    J Immunol; 1987 Jun; 138(12):4428-34. PubMed ID: 3295047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice vaccinated with a non-virulent, aromatic-dependent mutant of Salmonella choleraesuis die from challenge with its virulent parent but survive challenge with Salmonella typhimurium.
    Nnalue NA
    J Med Microbiol; 1990 Apr; 31(4):225-33. PubMed ID: 2139129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of gamma/delta T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis.
    Emoto M; Danbara H; Yoshikai Y
    J Exp Med; 1992 Aug; 176(2):363-72. PubMed ID: 1386870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on the interaction between mouse peritoneal macrophages and strains of Salmonella and Escherichia coli.
    JENKIN C; BENACERRAF B
    J Exp Med; 1960 Aug; 112(2):403-17. PubMed ID: 13789820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro.
    Lissner CR; Swanson RN; O'Brien AD
    J Immunol; 1983 Dec; 131(6):3006-13. PubMed ID: 6358358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.